Isabelle Schrauwen Selected Research

Otosclerosis

4/2022	A wide range of protective and predisposing variants in aggrecan influence the susceptibility for otosclerosis.
8/2019	Insufficient evidence for a role of SERPINF1 in otosclerosis.
7/2014	Genetic association analysis in a clinically and histologically confirmed otosclerosis population confirms association with the TGFB1 gene but suggests an association of the RELN gene with a clinically indistinguishable otosclerosis-like phenotype.
5/2012	COL1A1 association and otosclerosis: a meta-analysis.
9/2011	Association of COL1A1 and TGFB1 polymorphisms with otosclerosis in a Tunisian population.
9/2010	Genetic variants in RELN are associated with otosclerosis in a non-European population from Tunisia.
6/2010	The etiology of otosclerosis: a combination of genes and environment.
2/2010	Genetic variants in the RELN gene are associated with otosclerosis in multiple European populations.
12/2009	No evidence for association between the renin-angiotensin-aldosterone system and otosclerosis in a large Belgian-Dutch population.
3/2009	A genome-wide analysis identifies genetic variants in the RELN gene associated with otosclerosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Schrauwen Research Topics

Disease

16	Hearing Loss (Hearing Impairment) 10/2020 - 09/2007
14	Otosclerosis 04/2022 - 07/2007
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2017
2	Bicuspid Aortic Valve Disease 10/2021 - 10/2021
2	Nonsyndromic Deafness 01/2019 - 01/2016
2	Microcephaly 09/2018 - 01/2015
2	Conductive Hearing Loss 09/2010 - 07/2007
1	Fundus Albipunctatus 02/2022
1	Gaucher Disease (Gaucher's Disease) 01/2022
1	Left Ventricular Dysfunction 11/2021
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 08/2020
1	Paraplegia (Spastic Paraplegia) 01/2020
1	Multiple Abnormalities 01/2019
1	Bone Resorption 01/2019
1	Intellectual Disability (Idiocy) 09/2018
1	Autosomal Recessive Deafness 01/2017
1	Infantile Epileptic-Dyskinetic Encephalopathy 01/2017
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2017
1	Brain Diseases (Brain Disorder) 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 03/2014
1	Sensorineural Hearing Loss 09/2011
1	type 1 Stickler syndrome 07/2011
1	Measles 06/2010

Drug/Important Bio-Agent (IBA)

12	Capsules (Microcapsules)IBA 08/2019 - 07/2007
6	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 03/2009
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
2	TungstenIBA 10/2021 - 10/2021
2	Nonsense Codon (Nonsense Mutation)IBA 01/2019 - 01/2015
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 10/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2008 - 09/2007
1	Aggrecans (Aggrecan)IBA 04/2022
1	Retinal DehydrogenaseIBA 02/2022
1	SaposinsIBA 01/2022
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022
1	Fibrillin-1IBA 11/2021
1	Transaminases (Aminotransferases)IBA 08/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	5' Untranslated Regions (5' UTR)IBA 08/2019
1	3' Untranslated Regions (3' UTR)IBA 08/2019
1	Initiator Codon (Start Codon)IBA 01/2019
1	Aspartic Acid (Aspartate)FDA Link 01/2019
1	Serine (L-Serine)FDA Link 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016
1	Conditioned Culture MediaIBA 03/2014
1	A-Form DNA (A-DNA)IBA 01/2013
1	NucleotidesIBA 07/2011
1	FluoridesIBA 06/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2010
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2009
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 04/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2007
1	CollagenIBA 07/2007
1	alpha2 Subunit Collagen Type IIBA 07/2007